MOYES JAY M — SEC Form 4 filings
SEC reporting owner CIK 1191062. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-07.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-17 to 2026-07-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 4,000 shares, $13,666 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 66,000 shares, $307,063 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 6.
- Largest priced transaction: sale of 22,000 shares @ $7.22 ($158,796) in PUMA BIOTECHNOLOGY, INC., filed 2026-06-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | Director | 5 | — | 3 legs · 66,000 sh · $307,063 | 3 |
| Sintx Technologies, Inc. (SINT) | Director | 2 | 2 legs · 4,000 sh · $13,666 | — | — |
| BioCardia, Inc. (BCDA) | Director | 3 | — | — | 3 |
Form 4 filings — MOYES JAY M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-07 | 4 | BioCardia, Inc. (BCDA) | Grant/award (A): 8,000 (derivative) @ $0 | EDGAR |
| 2026-06-15 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 27,000 @ $0 · Sale (S): 22,000 @ $7.22 | EDGAR |
| 2026-02-25 | 4 | Sintx Technologies, Inc. (SINT) | Purchase (P): 1,000 @ $2.91 | EDGAR |
| 2025-12-10 | 4 | BioCardia, Inc. (BCDA) | Grant/award (A): 12,000 (derivative) @ $0 | EDGAR |
| 2025-08-27 | 4 | Sintx Technologies, Inc. (SINT) | Purchase (P): 3,000 @ $3.59 | EDGAR |
| 2025-06-17 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 22,000 @ $3.40 | EDGAR |
| 2025-06-13 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2024-10-16 | 4 | BioCardia, Inc. (BCDA) | Grant/award (A): 829 (derivative) @ $0 | EDGAR |
| 2024-06-21 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Grant/award (A): 27,000 @ $0 | EDGAR |
| 2024-06-17 | 4 | PUMA BIOTECHNOLOGY, INC. (PBYI) | Sale (S): 22,000 @ $3.34 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1191062 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →